GlassScriptPhysician profile
Steven J Snatic
NPI 1184670127
$15,285.23
in general payments reported to CMS, 2019-2025
47 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,076 · 2020: $852 · 2021: $3,045 · 2022: $3,008 · 2023: $3,507 · 2024: $2,797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,219 · Education: $85.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,218.71 |
| Education | $85.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,056.31 | 2021-2024 | Botox, Qulipta, Ubrelvy |
| Biogen, INC. | $1,395.02 | 2019-2024 | Vumerity, Tysabri, Avonex |
| Teva Pharmaceuticals USA, INC. | $1,153.20 | 2019-2024 | Ajovy, Austedo, Austedo Xr |
| Ucb, INC. | $1,051.71 | 2019-2024 | Briviact |
| Emd Serono, INC. | $731.91 | 2019-2023 | Mavenclad |
| Neurocrine Biosciences, INC. | $642.94 | 2022-2024 | Ingrezza, Ongentys |
| Genzyme Corporation | $561.81 | 2019-2023 | |
| Lundbeck LLC | $511.00 | 2020-2024 | Vyepti |
| Amgen INC. | $503.23 | 2019-2024 | Uplizna |
| Lilly USA, LLC | $486.11 | 2019-2024 | Emgality, Reyvow |
| Horizon Therapeutics Plc | $453.15 | 2022-2023 | Uplizna |
| Novartis Pharmaceuticals Corporation | $402.20 | 2019-2022 | |
| Allergan, INC. | $386.81 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $342.55 | 2022-2024 | Nuplazid |
| Celgene Corporation | $334.33 | 2020-2024 | Zeposia |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Snatic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.